Drospirenone/Ethinyl Estradiol (Gianvi®)

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

CompletedNCT01182207

Teva Pharmaceuticals USAHealthy

Start: 2006-07-31End: 2006-08-31Updated: 2010-12-08

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

CompletedNCT01182194

Teva Pharmaceuticals USAHealthy

Start: 2006-06-30End: 2006-08-31Updated: 2010-12-08